Insider Trading activities of Alexion Pharmaceuticals Inc insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alexion Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alexion Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Alexion Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ALXN. The reporting company's CIK number is 899866.
The total value of stock buying since 2005 is $394,084,487.
The total value of stock sales since 2005 is $1,002,882,574.
The total value of stock option exercises since 2005 is $145,784,408.



Table 2. Detailed insider stock purchases, sales, and option exercises of Alexion Pharmaceuticals Inc insiders (ALXN) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-07-27 Hallal David (SVP. Global Commercial Ops) Sale 50,555 106.94 5,406,351
2012-07-27 Hallal David (SVP. Global Commercial Ops) Option Ex 50,000 17.65 882,499
2012-07-27 Sinha Vikas (SVP & CFO) Sale 30,868 107.97 3,332,725
2012-07-27 Sinha Vikas (SVP & CFO) Option Ex 30,000 11.92 357,600
2012-07-27 Squinto Stephen P (EVP, Research & Development) Sale 100,668 107.11 10,782,750
2012-07-27 Squinto Stephen P (EVP, Research & Development) Option Ex 100,000 20.44 2,044,000
2012-07-27 Bell Leonard (CEO) Sale 62,000 107.55 6,667,790
2012-07-27 Bell Leonard (CEO) Option Ex 62,000 5.12 317,440
2012-07-27 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 171,713 107.28 18,420,855
2012-07-27 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 171,045 40.60 6,945,282
2012-07-09 Squinto Stephen P (EVP, Research & Development) Sale 50,000 101.04 5,052,150
2012-07-09 Squinto Stephen P (EVP, Research & Development) Option Ex 50,000 17.98 899,000
2012-07-09 Bell Leonard (CEO) Sale 108,000 101.04 10,911,996
2012-07-09 Bell Leonard (CEO) Option Ex 108,000 3.56 383,940
2012-06-15 Hallal David (SVP, Global Commercial Ops) Sale 14,308 93.67 1,340,230
2012-06-15 Hallal David (SVP, Global Commercial Ops) Option Ex 14,308 11.92 170,551
2012-06-15 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 42,578 94.00 4,002,332
2012-06-15 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 42,578 17.82 758,527
2012-06-08 Parven Alvin S (Director) Sale 30,000 91.01 2,730,300
2012-06-08 Parven Alvin S (Director) Option Ex 30,000 8.18 245,400
2012-06-07 Rummelt Andreas (Director) Sale 10,000 91.29 912,900
2012-06-06 Squinto Stephen P (EVP, Research & Development) Sale 50,000 90.00 4,500,000
2012-06-06 Squinto Stephen P (EVP, Research & Development) Option Ex 50,000 17.65 882,499
2012-05-29 Mathis Larry (Director) Sale 33,000 92.03 3,036,825
2012-05-29 Mathis Larry (Director) Option Ex 33,000 6.86 226,512
2012-05-29 Dubin Thomas I H (SVP and Chief Legal Officer) Sale 103,400 92.02 9,514,454
2012-05-29 Dubin Thomas I H (SVP and Chief Legal Officer) Option Ex 103,400 13.28 1,373,462
2012-05-14 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 18,088 8.18 147,959
2012-05-10 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 20,600 13.29 273,712
2012-05-09 Hallal David (SVP, Global Commercial Ops) Option Ex 10,000 8.16 81,600
2012-04-26 Sinha Vikas (SVP & CFO) Sale 48,000 89.94 4,317,120
2012-03-20 Sinha Vikas (SVP & CFO) Sale 21,996 89.93 1,978,100
2012-03-20 Sinha Vikas (SVP & CFO) Option Ex 21,996 10.29 226,338
2012-03-14 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 65,912 88.98 5,864,849
2012-03-14 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 65,912 8.46 557,417
2012-03-09 Norby R Douglas (Director) Sale 28,300 85.01 2,405,783
2012-03-09 Norby R Douglas (Director) Option Ex 28,300 8.18 231,494
2012-03-08 Norby R Douglas (Director) Sale 1,700 85.00 144,500
2012-03-08 Norby R Douglas (Director) Option Ex 1,700 8.18 13,906
2012-03-05 Parven Alvin S Buy 140 84.95 11,893
2012-02-28 Madri Joseph A (Director) Sale 16,000 84.02 1,344,320
2012-02-28 Madri Joseph A (Director) Option Ex 16,000 2.69 43,040
2012-02-23 Rummelt Andreas (Director) Sale 3,657 84.96 310,698
2012-02-23 Rummelt Andreas (Director) Option Ex 3,657 24.36 89,084
2012-02-23 Keller William R (Director) Sale 8,515 84.78 721,901
2012-02-23 Keller William R (Director) Option Ex 8,515 33.04 281,335
2012-02-23 Hallal David (SVP, Global Commercial Ops) Sale 40,000 85.50 3,420,000
2012-02-23 Hallal David (SVP, Global Commercial Ops) Option Ex 40,000 11.92 476,800
2012-02-23 Coissac Patrice (SVP & Pres. ALXN Pharma Int'l) Sale 90,000 85.03 7,652,700
2012-02-23 Coissac Patrice (SVP & Pres. ALXN Pharma Int'l) Option Ex 90,000 17.65 1,588,499
2012-02-22 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 89,871 83.64 7,517,259
2012-02-22 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 72,000 5.14 370,080
2012-02-21 Rummelt Andreas (Director) Sale 2,786 81.27 226,418
2012-02-21 Rummelt Andreas (Director) Option Ex 2,786 49.43 137,711
2012-02-21 Parven Alvin S (Director) Sale 5,450 81.51 444,229
2012-02-17 Veneman Ann M (Director) Sale 2,000 81.10 162,200
2012-02-17 Mathis Larry (Director) Sale 29,450 81.23 2,392,223
2012-02-17 Mathis Larry (Director) Option Ex 24,000 5.73 137,520
2012-02-17 Squinto Stephen P (EVP, Research & Development) Sale 55,260 81.65 4,511,868
2012-02-17 Squinto Stephen P (EVP, Research & Development) Option Ex 55,260 14.78 816,798
2012-02-14 Sinha Vikas (SVP & CFO) Sale 20,000 84.95 1,699,000
2012-02-14 Sinha Vikas (SVP & CFO) Option Ex 20,000 10.29 205,799
2012-02-13 Sinha Vikas (SVP & CFO) Sale 20,000 84.34 1,686,800
2012-02-13 Sinha Vikas (SVP & CFO) Option Ex 20,000 10.29 205,799
2012-02-03 Veneman Ann M (Director) Option Ex 3,115 .00 0
2012-02-03 Rummelt Andreas (Director) Option Ex 3,115 .00 0
2012-02-03 Keller William R (Director) Option Ex 3,115 .00 0
2012-02-03 Hallal David (SVP, Global Commercial Ops) Option Ex 10,000 .00 0
2012-02-03 Carmichael Clare (SVP, Chief HR Officer) Option Ex 3,000 .00 0
2012-02-03 Coissac Patrice (SVP & Pres. ALXN Pharma Int'l) Option Ex 8,000 .00 0
2012-02-03 Sinha Vikas (SVP & CFO) Option Ex 11,000 .00 0
2012-02-03 Mathis Larry (Director) Option Ex 3,115 .00 0
2012-02-03 Squinto Stephen P (EVP, Research & Development) Option Ex 13,000 .00 0
2012-02-03 Parven Alvin S (Director) Option Ex 3,115 .00 0
2012-02-03 Bell Leonard (CEO) Option Ex 36,000 .00 0
2012-02-03 Madri Joseph A (Director) Option Ex 3,115 .00 0
2012-02-03 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 8,000 .00 0
2012-02-03 Norby R Douglas (Director) Option Ex 3,115 .00 0
2012-02-03 Link Max (Director) Option Ex 3,115 .00 0
2012-01-30 Hallal David (SVP, Global Commercial Ops) Sale 1,896 74.51 141,270
2012-01-30 Sinha Vikas (SVP & CFO) Sale 3,480 74.51 259,294
2012-01-30 Squinto Stephen P (EVP, Research & Development) Sale 3,004 74.51 223,828
2012-01-30 Bell Leonard (CEO) Sale 9,569 74.51 712,986
2012-01-30 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 2,002 74.51 149,169
2012-01-27 Hallal David (SVP, Global Commercial Ops) Sale 554 74.41 41,223
2012-01-27 Sinha Vikas (SVP & CFO) Sale 863 74.41 64,215
2012-01-27 Squinto Stephen P (EVP, Research & Development) Sale 663 74.41 49,333
2012-01-27 Bell Leonard (CEO) Sale 2,264 74.41 168,464
2012-01-27 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 663 74.41 49,333
2012-01-10 Hallal David (SVP, Global Commercial Ops) Sale 536 75.00 40,200
2012-01-10 Sinha Vikas (SVP & CFO) Sale 1,036 75.00 77,700
2012-01-10 Squinto Stephen P (EVP, Research & Development) Sale 562 75.00 42,150
2012-01-10 Bell Leonard (CEO) Sale 2,226 75.00 166,950
2012-01-10 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 562 75.00 42,150
2012-01-09 Sinha Vikas (SVP & CFO) Sale 20,000 75.55 1,511,000
2012-01-09 Sinha Vikas (SVP & CFO) Option Ex 25,664 11.41 292,954
2011-12-30 Hallal David (SVP, Global Commercial Ops) Option Ex 3,000 8.16 24,480
2011-11-28 Hallal David (SVP, Global Commercial Ops) Sale 20,000 66.59 1,331,800
2011-11-28 Hallal David (SVP, Global Commercial Ops) Option Ex 20,000 11.92 238,400
2011-11-16 Coissac Patrice (SVP & Pres. ALXN Pharma Int'l) Sale 72,766 66.87 4,865,862
2011-11-16 Coissac Patrice (SVP & Pres. ALXN Pharma Int'l) Option Ex 72,766 17.41 1,266,856
2011-11-15 Bell Leonard (CEO) Sale 19,884 67.02 1,332,526
2011-11-15 Bell Leonard (CEO) Option Ex 24,884 4.37 108,618
2011-10-31 Parven Alvin S (Director) Sale 6,364 68.00 432,752
2011-10-31 Parven Alvin S (Director) Option Ex 6,364 4.93 31,374
2011-10-28 Norby R Douglas (Director) Sale 26,120 68.00 1,776,160
2011-10-28 Norby R Douglas (Director) Option Ex 26,120 5.24 136,868
2011-10-27 Norby R Douglas (Director) Sale 18,880 68.00 1,283,840
2011-10-27 Norby R Douglas (Director) Option Ex 18,880 5.55 104,784
2011-10-26 Bell Leonard (CEO) Sale 79,536 66.28 5,271,248
2011-10-26 Bell Leonard (CEO) Option Ex 99,536 4.37 434,474
2011-10-24 Rummelt Andreas (Director) Sale 9,015 69.01 622,125
2011-10-24 Rummelt Andreas (Director) Option Ex 9,015 33.48 301,795
2011-10-24 Squinto Stephen P (EVP, Research & Development) Sale 52,740 69.22 3,650,926
2011-10-24 Squinto Stephen P (EVP, Research & Development) Option Ex 52,740 11.92 628,660
2011-10-24 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 38,960 69.70 2,715,512
2011-10-24 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 38,960 5.46 212,721
2011-08-22 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 33,528 4.98 167,070
2011-08-08 Hallal David (SVP, Global Commercial Ops) Option Ex 5,000 8.16 40,800
2011-08-05 Hallal David (SVP, Global Commercial Ops) Option Ex 5,000 8.16 40,800
2011-07-28 Hallal David (SVP. Global Commercial Ops) Sale 36,872 57.33 2,113,871
2011-07-28 Hallal David (SVP. Global Commercial Ops) Option Ex 36,872 10.29 379,412
2011-07-27 Hallal David (SVP. Global Commercial Ops) Sale 555 57.27 31,784
2011-07-27 Sinha Vikas (SVP & CFO) Sale 871 57.27 49,882
2011-07-27 Squinto Stephen P (EVP, Research & Development) Sale 669 57.27 38,313
2011-07-27 Bell Leonard (CEO) Sale 4,557 81.70 372,011
2011-07-27 Madri Joseph A (Director) Sale 30,000 56.53 1,695,900
2011-07-27 Madri Joseph A (Director) Option Ex 30,000 3.90 117,000
2011-07-27 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 669 57.27 38,313
2011-07-26 Squinto Stephen P (EVP, Research & Development) Sale 28,000 57.34 1,605,520
2011-07-26 Squinto Stephen P (EVP, Research & Development) Option Ex 28,000 10.29 288,120
2011-07-25 Sinha Vikas (SVP & CFO) Sale 25,434 58.49 1,487,761
2011-07-25 Sinha Vikas (SVP & CFO) Option Ex 25,434 6.04 153,621
2011-07-25 Mathis Larry (Director) Sale 24,000 58.62 1,406,880
2011-07-25 Mathis Larry (Director) Option Ex 24,000 5.73 137,520
2011-07-25 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 31,512 58.48 1,842,821
2011-07-25 Dubin Thomas I H (SVP & Chief Legal Officer) Option Ex 31,512 4.03 126,993
2011-07-13 Sinha Vikas (SVP & CFO) Sale 14,566 52.53 765,151
2011-07-13 Sinha Vikas (SVP & CFO) Option Ex 14,566 6.90 100,505
2011-07-11 Hallal David (SVP, Global Commercial Ops) Sale 501 50.00 25,050
2011-07-11 Sinha Vikas (SVP & CFO) Sale 977 50.00 48,850
2011-07-11 Squinto Stephen P (EVP, Research & Development) Sale 502 50.00 25,100
2011-07-11 Bell Leonard (CEO) Sale 2,175 50.00 108,750
2011-07-11 Dubin Thomas I H (SVP & Chief Legal Officer) Sale 501 50.00 25,050
2011-04-01 Sinha Vikas (SVP & CFO) Sale 10,000 100.00 1,000,000
2011-04-01 Sinha Vikas (SVP & CFO) Option Ex 10,000 13.79 137,900
2011-03-10 Coissac Patrice (SVP, Pres ALXN Pharma Int'l) Sale 45,000 97.47 4,386,150
2011-03-10 Coissac Patrice (SVP, Pres ALXN Pharma Int'l) Option Ex 45,000 18.46 830,925
2011-03-03 Hallal David (SVP, Global Commercial Ops) Sale 4,900 99.21 486,128
2011-03-03 Hallal David (SVP, Global Commercial Ops) Option Ex 4,900 20.58 100,841

Insider trading activities including stock purchases, stock sales, and option exercises of ALXN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alexion Pharmaceuticals Inc (symbol ALXN, CIK number 899866) see the Securities and Exchange Commission (SEC) website.